JILL TIBKE: Open Payments
NPI 1902101934 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 24 payments from 8 companies in 2025. Trend: 2023 $756 · 2024 $543 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $111 |
| Abbott Laboratories | 4 | $97 |
| Amgen Inc. | 4 | $59 |
| Novo Nordisk Inc | 3 | $59 |
| Boston Scientific Corporation | 2 | $56 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| PFIZER INC. | 1 | $15 |
Products named: CARDIOMEMS, CAMZYOS, REPATHA, Wegovy, WATCHMAN FLX, VERQUVO, LEQVIO, ELIQUIS.
Industry payments across MO — which companies pay providers there.
